April 17th Local Leaders Global Impact Speakers Series
“Games for Good”
Developing a Viable Industry Business Model
When:
April 17, 2013
12 – 1 P.M.
Location:
Northeastern University – Seattle
401 Terry Ave N, Seattle 98109
(View Map)
Lunch will be provided.
To register, please click here.
Interactive Video Games are a major growth sector for the Seattle region. With approximately 350 companies in the Seattle area, we are the #1 cluster in the world for this rapidly-growing field. 170 million Americans play video games; 80% of them are adults, and the average time for kids each day is 2.1 hours! How can we channel this interest in video games and help educate children, empower people to develop community-based solutions to urgent social problems, and find cures for diseases? This event will bring together leading local game innovators and internationally-recognized gaming scholar, Dr. Magy Seif El-Nasr, to talk about how to evolve the business model of interactive entertainment to benefit the greater good. Please join us!
Magy Seif El-Nasr, PhD
Director of Game Educational Programs and Research, Northeastern
Director of the Game Design Program, Northeastern
Dr Seif El-Nasr is an associate professor in the Colleges of Computer and Information Sciences and Arts, Media and Design, where she directs the Game User Experience and Design Research Lab. Dr. Seif El-Nasr earned her Ph.D. from Northwestern University in computer science and her Master of Science in computer science from Texas A&M University. Magy’s award winning research focuses on enhancing game designs by developing tools and methods for evaluating and adapting game experiences. Her work is internationally known and cited in several game industry books, including Programming Believable Characters for Computer Games (Game Development Series) and Real-time Cinematography for Games. Magy is currently working on collaborative projects with Electronic Arts, Bardel Entertainment, and Pixel Ante. Dr. Seif El-Nasr has received multiple grants to support her research. She has published over 60 international peer reviewed articles on her work. In addition, her work has received several awards and recognition within the game industry and interactive narative communities. Notably, she received Best Paper Award at the International Conference of Virtual Storytelling 2003 and several citations in industry books and magazines.
John Williamson
Independent Producer and Author
John E. Williamson is a 20-year veteran of the Video Game Industry. He has shipped a wide range of titles on nearly every platform in that time period: from iOS to PS1 to Xbox 360 and everything in between. John has designed and produced over two dozen titles from E-Rated Arcade (Frogger) to M-Rated Survival Horror (SAW) as well as numerous Serious Games for the US Armed Forces. John entered video games through his Human Perception research in early virtual reality (VR) systems. He has explored a wide range of finance models from traditional publisher, Venture Capital and Crowd Sourcing and believes each has a role to play in Serious Games. His novel, The Red Cape, is due out this May.
Jeff Pobst
CEO, Hidden Path Entertainment
Jeff Pobst has been heavily involved in the gaming industry for almost fourteen years holding roles such as game programmer, producer, and chief operating officer. Jeff has shipped over 20 different game titles on four different platforms. He has also had the privilege of bringing games in the Half-Life, Homeworld, and Lord of the Rings franchises to market. Most recently, before breaking off to found HPE, Jeff was a group leader at Microsoft for the Xbox and Xbox 360 platforms.
Jason Robar
Game Industry Education and Startups Advisor, Economic Development Council of Seattle and King County
Jason Robar worked as a Games Technology Evangelist at Microsoft, where he created Microsoft’s first games relationships with Electronic Arts, Sony and Sega. Recently, he has spent increasing time on serious games and worked with the Department of Defense. Games he is credited with include Marvel Super Hero Squad Online, Carcassone, Vampire:The Masquerade, Dark Vengeance, and Havoc.
March 22 Speaker Series Recording
Thank you to the Seattle Channel for recording this event!
Read our recap on this event here.
Local Leaders Global Impact Speakers Series
“Bringing P4 Medicine to Patients and Society”
Predictive, Preventive, Personalized, Participatory
Friday, March 22, 2013
Noon – 1:00 P.M.
Imagine a day not too far into the future when a company will sequence your genome and your physician will combine that information with your medical records including your molecular and cellular information, as well as the effects of your environmental exposure. And these findings will be able to predict your probability of getting a specific disease or, alternatively, what you should do to optimize your wellness.
- How do we ensure that the healthcare delivery system is ready for this transformation?
- How has personalized medicine already changed clinical care and what is the prospect in the next 3-5 years?
- What does the healthcare community need to do or need to know?
Please join Dr. Lee Hood, President of the Institute for Systems Biology and Dr. Terry Fulmer, Dean of the Bouve College of Health Sciences at Northeastern University, as they explore the opportunities and challenges in bringing P4 Medicine to patients and society over the next decade.
Dr. Lee Hood will provide an overview of P4 Medicine and will then lead a panel discussion with top healthcare experts as they explore the current challenges of making P4 Medicine a reality.
Dr. Hood is a pioneer in the systems approach to biology and medicine. His research has focused on the study of molecular immunology, biotechnology and genomics. Dr. Hood’s professional career began at Caltech, where he and his colleagues developed the DNA gene sequencer and synthesizer and the protein synthesizer and sequencer–four instruments that paved the way for the successful mapping of the human genome. In addition to having received 17 honorary degrees from prestigious universities in the US and abroad, Dr. Hood has published more than 700 peer reviewed articles and currently holds 36 patents. He received the 2011 National Medal of Science, which was awarded to him during a White House ceremony in February 2013.
Click here to read a recent research paper co-authored by Lee Hood on P4 Medicine.
Panelists
Terry Fulmer, PhD, RN, FAAN
Dean, Bouvé College of Health Sciences, Northeastern University
Dr. Fulmer joined Northeastern University as Dean of the Bouve College of Health Sciences in fall, 2011.
Dr. Fulmer’s program of research focuses on acute care of the elderly and specifically, elder abuse and neglect. She
is a member of the Institute of Medicine and has received the status of Fellow in the American Academy of Nursing,
the Gerontological Society of America, and the New York Academy of Medicine. She completed a Brookdale National
Fellowship and is a Distinguished Practitioner of the National Academies of Practice. Dr. Fulmer was the first nurse
to be elected to the board of the American Geriatrics Society and the first nurse to serve as the president of the
Gerontological Society of America. She is currently Vice-Chair of the board of the New York Academy of Medicine and NortheasternUniversitySeattle a board member of the Institute for Healthcare Improvement.
Dr. C. Anthony Blau
Co-Director, Institute for Stem Cell and Regenerative Medicine, University of Washington
Dr. Blau is a University of Washington professor of medicine in the Division of Hematology, the co-director of the University of Washington’s Institute for Stem Cell and Regenerative Medicine, and the co-director of the Fred Hutchinson and University of Washington Stem and Progenitor Cell Biology Program. Dr. Blau has added substantially to the literature of human embryonic stem cells and has made key discoveries in the relationship between erythropoietin (the protein used to make red blood cells) and cancer progression. Additionally, Dr. Blau is pioneering a “smarter war on cancer” by taking a systems medicine approach to cancer treatment. In “N of 1” experiments, Dr. Blau is having each patient serve as his or her own controls, and using serial molecular monitoring to test drug treatment efficacy.
